These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25332207)

  • 61. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
    Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
    J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Calcineurin-NFATc regulates type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) expression during cardiac remodeling.
    Sankar N; deTombe PP; Mignery GA
    J Biol Chem; 2014 Feb; 289(9):6188-98. PubMed ID: 24415751
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation.
    Kirschmer N; Bandleon S; von Ehrlich-Treuenstätt V; Hartmann S; Schaaf A; Lamprecht AK; Miranda-Laferte E; Langsenlehner T; Ritter O; Eder P
    PLoS One; 2016; 11(12):e0168446. PubMed ID: 27992507
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. β-adrenergic signaling inhibits Gq-dependent protein kinase D activation by preventing protein kinase D translocation.
    Nichols CB; Chang CW; Ferrero M; Wood BM; Stein ML; Ferguson AJ; Ha D; Rigor RR; Bossuyt S; Bossuyt J
    Circ Res; 2014 Apr; 114(9):1398-409. PubMed ID: 24643961
    [TBL] [Abstract][Full Text] [Related]  

  • 67. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
    Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W
    BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.
    Ago T; Yang Y; Zhai P; Sadoshima J
    J Cardiovasc Transl Res; 2010 Aug; 3(4):304-13. PubMed ID: 20559781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
    Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
    Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways.
    Cui S; Cui Y; Li Y; Zhang Y; Wang H; Qin W; Chen X; Ding S; Wu D; Guo H
    Biochem Biophys Res Commun; 2018 Dec; 506(4):805-811. PubMed ID: 30389139
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
    Liu W; Zi M; Jin J; Prehar S; Oceandy D; Kimura TE; Lei M; Neyses L; Weston AH; Cartwright EJ; Wang X
    Circ Res; 2009 Apr; 104(7):905-14. PubMed ID: 19265040
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
    Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
    Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling.
    Pillai VB; Sundaresan NR; Kim G; Samant S; Moreno-Vinasco L; Garcia JG; Gupta MP
    Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H415-26. PubMed ID: 23203961
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
    Wang K; Long B; Zhou J; Li PF
    J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
    Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
    Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
    Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
    Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
    Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
    Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure.
    Yi XP; Zhou J; Baker J; Wang X; Gerdes AM; Li F
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Jan; 282(1):13-23. PubMed ID: 15584034
    [TBL] [Abstract][Full Text] [Related]  

  • 80. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
    Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C
    Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.